Single-nucleus RNA sequencing (snRNA-Seq) of patient glioblastomas (n = 9) demonstrated that MES-like cells within NF1-mutant tumors exhibited increased MEK activation. The gene discussed is MAP2K7; the disease is glioblastoma.